(Q35116075)

6 August 2017

1 reference

title

An introduction to cost-effectiveness and cost-benefit analysis of pharmacogenomics (English)

1 reference

6 August 2017

An introduction to cost-effectiveness and cost–benefit analysis of pharmacogenomics (English)

1 reference

https://api.crossref.org/works/10.1517/PHGS.4.3.231.22691

28 December 2023

1 reference

cost-effectiveness analysis

1 reference

based on heuristic

inferred from title

cost–benefit analysis

1 reference

1 reference

https://api.crossref.org/works/10.1517/PHGS.4.3.231.22691

28 December 2023

1 reference

https://api.crossref.org/works/10.1517/PHGS.4.3.231.22691

28 December 2023

1 reference

https://api.crossref.org/works/10.1517/PHGS.4.3.231.22691

28 December 2023

2

David Veenstra

1 reference

6 August 2017

Stephanie Van Bebber

3

1 reference

6 August 2017

Julie Sakowski

4

1 reference

6 August 2017

Kathryn A. Phillips

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12718713

28 December 2023

David Veenstra

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12718713

28 December 2023

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=12718713

28 December 2023

publication date

1 May 2003

1 reference

full work available at URL

6 August 2017

https://www.futuremedicine.com/doi/pdf/10.1517/phgs.4.3.231.22691

1 reference

https://api.crossref.org/works/10.1517/PHGS.4.3.231.22691

28 December 2023

1 reference

6 August 2017

4

1 reference

6 August 2017

3

1 reference

6 August 2017

231-239

1 reference

Potential role of pharmacogenomics in reducing adverse drug reactions: a systematic review

6 August 2017

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.4.3.231.22691

Shattuck lecture--medical and societal consequences of the Human Genome Project.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.4.3.231.22691

Implications of the Human Genome Project for medical science.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.4.3.231.22691

Population screening in the age of genomic medicine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.4.3.231.22691

Use of genotypic resistance testing to guide hiv therapy: clinical impact and cost-effectiveness

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.4.3.231.22691

Pretreatment evaluation of chronic hepatitis C: risks, benefits, and costs

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.4.3.231.22691

Cost-effectiveness of screening and extended anticoagulation for carriers of both factor V Leiden and prothrombin G20210A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.4.3.231.22691

Cost effectiveness of interferon alpha2b combined with ribavirin for the treatment of chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.4.3.231.22691

Genomic medicine--a primer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.4.3.231.22691

Health and economic benefits of increased beta-blocker use following myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.4.3.231.22691

Pharmacogenetic challenges for the health care system

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.4.3.231.22691

Getting ready for gene-based medicine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.4.3.231.22691

Screening for factor V Leiden mutation before prescribing combination oral contraceptives

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.4.3.231.22691

The cost-effectiveness of interleukin-1 genetic testing for periodontal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.4.3.231.22691

Assessing the cost-effectiveness of pharmacogenomics

21 January 2018

2

1 reference

https://api.crossref.org/works/10.1517/PHGS.4.3.231.22691

28 December 2023

Identifiers

1 reference

release_cqhckilvcrdtjizp5tsl7cfnn4

6 August 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/cqhckilvcrdtjizp5tsl7cfnn4

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference